Artrya
web2Artrya is an Australian medical technology company developing artificial intelligence software...
About
Artrya is an Australian medical technology company developing artificial intelligence software that helps healthcare professionals analyze cardiac CT scans for signs of coronary artery disease. Its Salix software processes coronary computed tomography angiography images to identify and characterize plaque buildup, assess arterial narrowing, and support clinical interpretation. The technology is intended for physicians and healthcare organizations evaluating patients with suspected or established coronary artery disease. Salix provides visualization and measurement tools that complement clinical assessment rather than replace medical judgment. The company has obtained specified product clearances in Australia and the United States, while availability in other jurisdictions remains subject to applicable requirements.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Artrya profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy